Why Drug Price Negotiation Has Staying Power

Why Drug Price Negotiation Has Staying Power   In his Axios column, Drew Altman looks beyond Medicare to what’s at stake for employers and workers in the debate about the government negotiating prescription drug prices.

 

Full Column on KFF.org Quick Read: Axios Column

 

Filling the need for trusted information on national health issues, KFF is a nonprofit organization based in San Francisco, California. kff.org  |  khn.org

 

Did someone forward this to you? Click here to sign up for emails from KFF. This email was sent to john.dubas@premiersmi.com. Update your email preferences to choose the types of emails you receive. Or, permanently unsubscribe from all future emails.  If you need help or have questions, please send an email to subscriptions@kff.org. Please do not reply to this email as this address is not monitored. KFF 185 Berry Street Suite 2000 San Francisco, CA 94107